2nd Jun 2009 17:04
|
For immediate release |
2 June 2009 |
MINSTER PHARMACEUTICALS PLC("Minster" or "the Company")
Annual Report & Accounts and Notice of AGM
Minster Pharmaceuticals plc (AIM: MPM), the drug development company specialising in neurological and psychiatric disorders, announces that it has posted to shareholders the Annual Report and Financial Statements for the year ended 31 March 2009, together with the Notice of Annual General Meeting ("AGM") and the form of proxy for use at the AGM.
The AGM will be held at the offices of the Company at 107-111 Fleet Street, London, EC4A 2AB, on Tuesday, 30 June 2009 at 10.00 a.m..
Copies of these documents are available free of charge from the Company's Registered Office at Audley End Business Centre, The Old Forge, London Road, Wendens Ambo, Saffron Walden CB11 4JL, and are also available on the Company's website at www.minsterpharma.com.
For further information:
|
Minster Pharmaceuticals plc |
Tel: +44 (0) 1799 506623 |
|
John Russell, Chairman and Interim CEO |
|
|
Karl Keegan, Chief Financial Officer |
|
|
|
|
|
Buchanan Communications |
Tel: +44 (0) 20 7466 5000 |
|
Mark Court / Rebecca Skye Dietrich / Catherine Breen |
|
|
|
|
|
Nomura Code Securities Limited |
Tel: +44 (0) 20 7776 1200 |
|
Chris Collins / Richard Potts |
|
Notes for editors:
About Minster Pharmaceuticals plc
Minster Pharmaceuticals is a drug development company focussed on neurological and psychiatric disorders. Its principal pipeline assets are tonabersat and sabcomeline. Worldwide rights to both compounds were acquired from GlaxoSmithKline and the compounds benefit from comprehensive safety tolerance data as a result of investment by GSK.
Tonabersat is the leading compound in an exciting new class of selective drugs designated as neuronal gap junction blockers. Sabcomeline, a muscarinic partial agonist, has potential in the treatment of chronic schizophrenia and the strategy for its further clinical development is currently under consideration.
Minster joined the AIM market in February 2005 and trades under the symbol MPM. For further information please visit www.minsterpharma.com.
Related Shares:
MPM.L